1MBBCH, Department of Dermatology and Venerology, Faculty of Medicine, October 6 University hospitals, Giza, Egypt
2MD, Department of Dermatology and Venerology, Faculty of Medicine, October 6 University, Giza, Egypt
3MD, Department of Dermatology and Venerology, Faculty of Medicine, Kasr Al-Ainy University, Giza, Egypt
Atrophic acne scars represent a common and therapeutically challenging sequela of acne vulgaris, with significant psychosocial and quality-of-life implications. Advances in regenerative medicine have expanded treatment strategies beyond conventional energy-based and surgical approaches. Among these, exosome-based therapies and injectable skin boosters have emerged as promising modalities capable of enhancing dermal remodeling, angiogenesis, and extracellular matrix regeneration. This review provides a comprehensive overview of acne scar pathophysiology, traditional treatment modalities, and emerging regenerative approaches, with particular emphasis on exosomes as biological drug delivery systems and injectable skin boosters as biorevitalization agents. Current clinical evidence, mechanisms of action, safety considerations, and future perspectives are discussed in the context of cutaneous drug delivery.
How to cite this article: Bedair H, Hassan NB and Nada HI, Exosomes and Injectable Skin Boosters in the Management of Atrophic Acne Scars: Implications for Cutaneous Regeneration and Drug Delivery. Int J Drug Deliv Technol. 2026;16(5s): 834-836. DOI: 10.25258/ijddt.16.5s.99
Source of support: Nil.
Conflict of interest: None